Shares of Eden Research plc (LON:EDEN – Get Free Report) fell 13.2% during trading on Tuesday . The stock traded as low as GBX 2.26 ($0.03) and last traded at GBX 2.37 ($0.03). Approximately 1,775,147 shares changed hands during mid-day trading, an increase of 133% from the average session volume of 762,776 shares. The stock had previously closed at GBX 2.73 ($0.04).
Eden Research Trading Down 1.9 %
The company has a debt-to-equity ratio of 1.26, a current ratio of 3.80 and a quick ratio of 2.42. The business’s 50-day moving average is GBX 3.34 and its 200 day moving average is GBX 3.70. The firm has a market capitalization of £13.87 million, a P/E ratio of -9.11 and a beta of 0.92.
Insiders Place Their Bets
In other news, insider Alexander John Abrey acquired 167,947 shares of the business’s stock in a transaction that occurred on Tuesday, March 4th. The stock was acquired at an average price of GBX 3 ($0.04) per share, with a total value of £5,038.41 ($6,542.54). Also, insider Sean M. Smith bought 426,986 shares of the company’s stock in a transaction dated Tuesday, April 1st. The stock was purchased at an average price of GBX 234 ($3.04) per share, with a total value of £999,147.24 ($1,297,425.32). Insiders have acquired a total of 1,391,473 shares of company stock worth $103,604,725 in the last quarter. Corporate insiders own 14.02% of the company’s stock.
About Eden Research
Eden Research is the only UK-listed company focused on biopesticides for sustainable agriculture. It develops and supplies innovative biopesticide products and natural microencapsulation technologies to the global crop protection, animal health and consumer products industries.
Eden’s products are formulated with terpene active ingredients, based on natural plant defence metabolites.
Recommended Stories
- Five stocks we like better than Eden Research
- What is the Euro STOXX 50 Index?
- Homebuilders in Freefall: Bargain Opportunity or Falling Knife?
- What is a Low P/E Ratio and What Does it Tell Investors?
- The 3 Most Talked About Investments on WallStreetBets Right Now
- How to Effectively Use the MarketBeat Ratings Screener
- Analyst Targets Signal More Growth in CrowdStrike Stock
Receive News & Ratings for Eden Research Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Eden Research and related companies with MarketBeat.com's FREE daily email newsletter.
